Elicio Therapeutics, Inc.
HealthcareNASDAQ:ELTX · NASDAQ Global Market
+$0.91 today
Vol 0.12M · Avg 0.13M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+95.39%
Period High
$14.85
Period Low
$7.54
Latest
$14.85
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Nkarta, Inc.
NASDAQ:NKTX
$204.62M
Molecular Partners AG
NASDAQ:MOLN
$154.17M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$109.08M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$105.29M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$102.67M
PepGen Inc.
NASDAQ:PEPG
$101.68M
Cassava Sciences, Inc.
SAVA
$63.77M
Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
$49.65M
Actuate Therapeutics Inc
ACTU
$48.33M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest ELTX filing?
The latest filing shown is 8-K dated May 11, 2026.
How many recent filings does ELTX have?
Intrinsic Alpha currently shows 20 recent filings for ELTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.